Inhaled IL-10 suppresses lung tumorigenesis via abrogation of inflammatory macrophage–th17 cell axis

Q Li, CD Anderson, NK Egilmez - The Journal of Immunology, 2018 - journals.aai.org
Intratracheal administration of a novel IL-10 formulation suppressed IL-17–driven, CD4+ T
cell–dependent tumorigenesis in the LSL-K-ras G12D murine lung cancer model. Analysis …
被引用次数：30 相关文章

Inhaled IL-10 Suppresses Lung Tumorigenesis via Abrogation of Inflammatory Macrophage–Th17 Cell Axis

Q Li, CD Anderson, NK Egilmez - The Journal of Immunology, 2018 - journals.aai.org
Intratracheal administration of a novel IL-10 formulation suppressed IL-17–driven, CD4+ T
cell–dependent tumorigenesis in the LSL-K-rasG12D murine lung cancer model. Analysis of …

Inhaled IL-10 Suppresses Lung Tumorigenesis via Abrogation of Inflammatory Macrophage–Th17 Cell Axis

Q Li, CD Anderson, NK Egilmez - The Journal of Immunology, 2018 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Intratracheal administration of a novel IL-10
formulation suppressed IL-17–driven, CD4+ T cell–dependent tumorigenesis in the LSL-K …

Inhaled IL-10 Suppresses Lung Tumorigenesis via Abrogation of Inflammatory Macrophage-Th17 Cell Axis

Q Li, CD Anderson, NK Egilmez - Journal of immunology …, 2018 - pubmed.ncbi.nlm.nih.gov
Intratracheal administration of a novel IL-10 formulation suppressed IL-17-driven, CD4+ T
cell-dependent tumorigenesis in the LSL-K-ras G12D murine lung cancer model. Analysis of …

Inhaled IL-10 Suppresses Lung Tumorigenesis via Abrogation of Inflammatory Macrophage-Th17 Cell Axis.

Q Li, CD Anderson, NK Egilmez - Journal of Immunology (Baltimore …, 2018 - europepmc.org
Intratracheal administration of a novel IL-10 formulation suppressed IL-17-driven, CD4+ T
cell-dependent tumorigenesis in the LSL-K-ras G12D murine lung cancer model. Analysis of …